Literature DB >> 26208141

TLR2 and TLR4 Expression and Inflammatory Cytokines are Altered in the Airway Epithelium of Those with Alcohol Use Disorders.

Kristina L Bailey1,2, Debra J Romberger1,2, Dawn M Katafiasz1, Art J Heires1,2, Joseph H Sisson1, Todd A Wyatt1,2,3, Ellen L Burnham4.   

Abstract

BACKGROUND: The lung has a highly regulated system of innate immunity to protect itself from inhaled microbes and toxins. The first line of defense is mucociliary clearance, but if invaders overcome this, inflammatory pathways are activated. Toll-like receptors (TLRs) are expressed on the airway epithelium. Their signaling initiates the inflammatory cascade and leads to production of inflammatory cytokines such as interleukin (IL)-6 and IL-8. We hypothesized that airway epithelial insults, including heavy alcohol intake or smoking, would alter the expression of TLRs on the airway epithelium.
METHODS: Bronchoscopy with bronchoalveolar lavage and brushings of the airway epithelium was performed in otherwise healthy subjects who had normal chest radiographs and spirometry. A history of alcohol use disorders (AUDs) was ascertained using the Alcohol Use Disorders Identification Test (AUDIT), and a history of cigarette smoking was also obtained. Age, gender, and nutritional status in all groups were similar. We used real-time polymerase chain reaction (PCR) to quantitate TLR1 to 9 and enzyme-linked immune assay to measure tumor necrosis factor-α, IL-6, and IL-8.
RESULTS: Airway brushings were obtained from 26 nonsmoking/non-AUD subjects, 28 smoking/non-AUD subjects, 36 smoking/AUD subjects, and 17 nonsmoking/AUD subjects. We found that TLR2 is up-regulated in AUD subjects, compared to nonsmoking/non-AUD subjects, and correlated with their AUDIT scores. We also measured a decrease in TLR4 expression in AUD subjects that correlated with AUDIT score. IL-6 and IL-8 were also increased in bronchial washings from AUD subjects.
CONCLUSIONS: We have previously demonstrated in normal human bronchial epithelial cells that in vitro alcohol exposure up-regulates TLR2 through a NO/cGMP/PKG-dependent pathway, resulting in up-regulation of inflammatory cytokine production after Gram-positive bacterial product stimulation. Our current translational study confirms that TLR2 is also up-regulated in humans with AUDs.
Copyright © 2015 by the Research Society on Alcoholism.

Entities:  

Keywords:  Airway Epithelium; Cytokines; Human; Toll-Like Receptors

Mesh:

Substances:

Year:  2015        PMID: 26208141      PMCID: PMC4843766          DOI: 10.1111/acer.12803

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  30 in total

1.  In vivo ethanol exposure down-regulates TLR2-, TLR4-, and TLR9-mediated macrophage inflammatory response by limiting p38 and ERK1/2 activation.

Authors:  Joanna Goral; Elizabeth J Kovacs
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 2.  Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis.

Authors:  A V Samokhvalov; H M Irving; J Rehm
Journal:  Epidemiol Infect       Date:  2010-04-12       Impact factor: 2.451

3.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

4.  Chronic ethanol downregulates PKA activation and ciliary beating in bovine bronchial epithelial cells.

Authors:  T A Wyatt; J H Sisson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-09       Impact factor: 5.464

Review 5.  Possible contributors to the gender differences in alcohol use and problems.

Authors:  Susan Nolen-Hoeksema; Lori Hilt
Journal:  J Gen Psychol       Date:  2006-10

6.  Are smokers with alcohol disorders less likely to quit?

Authors:  N Breslau; E Peterson; L Schultz; P Andreski; H Chilcoat
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

7.  Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa.

Authors:  Ruxana T Sadikot; Heng Zeng; Myungsoo Joo; M Brett Everhart; Taylor P Sherrill; Bo Li; Dong-sheng Cheng; Fiona E Yull; John W Christman; Timothy S Blackwell
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

8.  High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.

Authors:  Fulton T Crews; Liya Qin; Donna Sheedy; Ryan P Vetreno; Jian Zou
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

9.  Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking.

Authors:  Ellen L Burnham; Elizabeth J Kovacs; Christopher S Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-19       Impact factor: 5.464

10.  Alcohol functionally upregulates Toll-like receptor 2 in airway epithelial cells.

Authors:  Kristina L Bailey; Todd A Wyatt; Debra J Romberger; Joseph H Sisson
Journal:  Alcohol Clin Exp Res       Date:  2008-12-19       Impact factor: 3.455

View more
  9 in total

1.  The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.

Authors:  Jeanette Gaydos; Alicia McNally; Ellen L Burnham
Journal:  Alcohol       Date:  2018-09-05       Impact factor: 2.405

2.  Malondialdehyde-Acetaldehyde (MAA) Protein Adducts Are Found Exclusively in the Lungs of Smokers with Alcohol Use Disorders and Are Associated with Systemic Anti-MAA Antibodies.

Authors:  Muna Sapkota; Ellen L Burnham; Jane M DeVasure; Jenea M Sweeter; Carlos D Hunter; Michael J Duryee; Lynell W Klassen; Kusum K Kharbanda; Joseph H Sisson; Geoffrey M Thiele; Todd A Wyatt
Journal:  Alcohol Clin Exp Res       Date:  2017-11-04       Impact factor: 3.455

3.  Alcohol and cannabis use alter pulmonary innate immunity.

Authors:  Kristina L Bailey; Todd A Wyatt; Dawn M Katafiasz; Keenan W Taylor; Art J Heires; Joseph H Sisson; Debra J Romberger; Ellen L Burnham
Journal:  Alcohol       Date:  2018-11-10       Impact factor: 2.405

4.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

Review 5.  Chronic Inflammation in Immune Aging: Role of Pattern Recognition Receptor Crosstalk with the Telomere Complex?

Authors:  Shyam Sushama Jose; Kamila Bendickova; Tomas Kepak; Zdenka Krenova; Jan Fric
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

6.  The Effect of Alcohol Consumption on the Risk of ARDS: A Systematic Review and Meta-Analysis.

Authors:  Evangelia Simou; Jo Leonardi-Bee; John Britton
Journal:  Chest       Date:  2017-12-27       Impact factor: 9.410

7.  COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality.

Authors:  Kristina L Bailey; Harlan Sayles; James Campbell; Neha Khalid; Madyson Anglim; Jana Ponce; Todd A Wyatt; James C McClay; Ellen L Burnham; Alfred Anzalone; Corrine Hanson
Journal:  Alcohol Clin Exp Res       Date:  2022-05-02       Impact factor: 3.928

8.  Alcohol Use Disorders Are Associated With a Unique Impact on Airway Epithelial Cell Gene Expression.

Authors:  Kristina L Bailey; Harry Smith; Susan K Mathai; Jonathan Huber; Mark Yacoub; Ivana V Yang; Todd A Wyatt; Katerina Kechris; Ellen L Burnham
Journal:  Alcohol Clin Exp Res       Date:  2020-07-01       Impact factor: 3.455

9.  ABCF1 Regulates dsDNA-induced Immune Responses in Human Airway Epithelial Cells.

Authors:  Quynh T Cao; Jennifer A Aguiar; Benjamin J-M Tremblay; Nadin Abbas; Nicholas Tiessen; Spencer Revill; Nima Makhdami; Anmar Ayoub; Gerard Cox; Kjetil Ask; Andrew C Doxey; Jeremy A Hirota
Journal:  Front Cell Infect Microbiol       Date:  2020-09-16       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.